Raymond James Trust’s ResMed RMD Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2024
Q3 | $346K | Buy |
1,419
+1
| +0.1% | +$244 | 0.01% | 965 |
|
2024
Q2 | $271K | Sell |
1,418
-2
| -0.1% | -$383 | 0.01% | 1027 |
|
2024
Q1 | $281K | Buy |
1,420
+2
| +0.1% | +$396 | 0.01% | 1010 |
|
2023
Q4 | $244K | Buy |
1,418
+42
| +3% | +$7.23K | 0.01% | 1045 |
|
2023
Q3 | $203K | Sell |
1,376
-64
| -4% | -$9.46K | 0.01% | 1080 |
|
2023
Q2 | $315K | Buy |
1,440
+19
| +1% | +$4.16K | 0.01% | 868 |
|
2023
Q1 | $311K | Buy |
1,421
+54
| +4% | +$11.8K | 0.01% | 853 |
|
2022
Q4 | $285K | Buy |
1,367
+6
| +0.4% | +$1.25K | 0.01% | 854 |
|
2022
Q3 | $297K | Buy |
1,361
+20
| +1% | +$4.36K | 0.01% | 794 |
|
2022
Q2 | $281K | Sell |
1,341
-24
| -2% | -$5.03K | 0.01% | 834 |
|
2022
Q1 | $331K | Sell |
1,365
-14
| -1% | -$3.4K | 0.01% | 829 |
|
2021
Q4 | $359K | Buy |
1,379
+32
| +2% | +$8.33K | 0.01% | 795 |
|
2021
Q3 | $355K | Sell |
1,347
-8
| -0.6% | -$2.11K | 0.01% | 770 |
|
2021
Q2 | $334K | Sell |
1,355
-1
| -0.1% | -$246 | 0.01% | 810 |
|
2021
Q1 | $263K | Buy |
+1,356
| New | +$263K | 0.01% | 889 |
|